This interactive map visualises the current state of genomic data integration and molecular diagnostics implementation across selected European countries. It reflects findings from EAPM’s national factsheets, assessing the readiness and challenges in adopting Next-Generation Sequencing (NGS) and health data governance to support personalised cancer care.
Countries are highlighted based on their overall level of maturity in:
This classification provides a snapshot of progress and key barriers, supporting policymakers, clinicians, and stakeholders in identifying priority areas for action and collaboration.
Legend:
🟢 Advanced Integration
Countries with mature data infrastructure, routine NGS use, established governance, and existing reimbursement mechanisms.
🟡 Developing Capacity
Countries with established infrastructure and some NGS application but facing challenges in reimbursement, workforce capacity, or standardisation.
🟠 Emerging Efforts
Countries building infrastructure and initial data integration, but with significant needs in governance, workforce, and diagnostics access.